Capricor Therapeutics Inc Stock
We can see a decrease in the price for Capricor Therapeutics Inc. Compared to yesterday it has lost -€0.550 (-2.220%).
For the coming years our community has positive and negative things to say abot the Capricor Therapeutics Inc stock. Criterium "Return on equity" gathered the most positive votes but regarding "Return on equity" there were negative voices in the community.
Pros and Cons of Capricor Therapeutics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Capricor Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Capricor Therapeutics Inc | -2.220% | 27.907% | 17.191% | 67.127% | -5.653% | 491.542% | 290.323% |
| Biocryst Pharmaceuticals | -0.690% | 10.691% | 11.041% | -29.256% | -3.661% | -33.530% | -33.600% |
| Heron Therapeutics Inc. | 0.970% | 4.317% | -16.530% | -37.844% | -8.887% | -58.673% | -93.265% |
| Madrigal Pharmaceuticals inc. | -2.070% | -5.401% | -14.246% | 10.725% | -25.858% | 30.141% | 265.760% |
News
Here's Why This Biotechnology Skyrocketed by 439% in December
Capricor Therapeutics (NASDAQ: CAPR) stock rose an incredible 439.4% in December, according to data provided by S&P Global Market Intelligence. The move followed the company's announcement of
